Active — Not RecruitingNot Applicable

Elements Vital to Treat Obesity Study

United States524 participantsStarted 2021-03-16

Plain-language summary

The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP), to evaluate program weight-loss success and cost-effectiveness.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * BMI 30-45 * Weight stable * Own a Smartphone and be willing to install our Smartphone app * Willing to conduct video conference calls with study staff Exclusion Criteria: * Enrolled in any formal weight loss program * Taking anti-obesity medications * Not taking medications that may cause weight gain * Unstable medical conditions * Diabetes requiring insulin supplementation * Crohn's Disease * Diagnosis of obstructive sleep apnea requiring intervention (i.e., CPAP) * Assistive devices for mobility * Hospitalizations for a psychiatric disorder within the past 5 years * Cardiovascular disease symptoms while performing moderate intensity exercise * Pregnancy, trying to get pregnant, or lactating. * Bulimia or binge eating disorder * Reports of active suicidal ideation * Current substance abuse or dependence besides nicotine dependence

What they're measuring

Weight

Timeframe: Baseline to 6-Months

Trial details

NCT IDNCT04708769

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-15

View on ClinicalTrials.gov More Obesity trials